New Israeli drug successful vs fatal COVID-19 immune response in initial study — expert

The biggest advantage of our drug is that it can be produced efficiently, effectively, rapidly, it's easy to produce at low cost, and [it has shown] no side effects," Dr. Nadir Arber of Tel Aviv Sourasky Medical Center said.


Full Post on Source: New Israeli drug successful vs fatal COVID-19 immune response in initial study — expert

 

Philippines News © 2015 | Distributed By My Blogger Themes | Designed By Templateism.com